Терапевтический архив (Nov 2016)

Insulin resistance and chronic hepatitis C

  • L I Tkachenko,
  • V V Maleev

DOI
https://doi.org/10.17116/terarkh2016881129-36
Journal volume & issue
Vol. 88, no. 11
pp. 29 – 36

Abstract

Read online

Aim. To estimate the spread of insulin resistance (IR) in patients with chronic hepatitis C (CHC) and to define the role of IR in the development of hepatic steatosis (HS) and in the progression of liver fibrosis (LF), as well as the impact of IR on the results of antiviral therapy (AVT). Subjects and methods. A total of 211 patients with CHC were examined. A comparison group consisted of 75 patients with chronic hepatitis B (CHB). The patients were divided according to the presence and absence of IR and type 2 diabetes mellitus (DM). IR was analyzed in patients with CHC with a body mass index (BMI) of

Keywords